Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine
IMPACT
IMPACT
Sponsor study identifier
Secondary identifiers
interventional
1,590
1 country
1
Study Start
May 1, 2017
Actual (reported)Primary Completion
June 30, 2024
Actual (reported)Study Completion
June 30, 2024
Actual (reported)A randomized controlled trial to:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2017
Actual (reported)June 10, 2021
Actual (reported)June 15, 2021
Actual (reported)June 30, 2024
Actual (reported)June 30, 2024
Actual (reported)September 23, 2026
Actual (reported)Average Percentage of Recommended Quality Health Indicator Services Accessed by Participants to Assess Efficacy
The total average percentage of the 17 recommended Quality Health Indicator screenings and services that were accessed by participants to assess efficacy. Recommended QHI screenings are as follows: General medical examination; blood analysis; urine analysis; cardiogram; mammogram; cervical cancer screening; prostate cancer screening; hepatitis B screening; hepatitis C screening; HIV screening; CD4 or viral load; ART treatment; TB screening; TB treatment; received take-home MMT; adequate MMT dose; on MMT for 12 months. Data presented here is for adjusted average values of services accessed at 24 months.
every 6 months up to 24 months
Average Percentage of Recommended Primary Quality Health Indicator Services Accessed to Assess Efficacy
every 6 months up to 24 months
Average Percentage of Recommended Specialty Quality Health Indicator Services Accessed to Assess Efficacy
every 6 months up to 24 months
Co-location of clinical services for HIV and PWID patients
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
European Institute for Public Health Policy
Kyiv, Ukraine
Machavariani E, Esserman D, Dumchev K, Filippovych M, Pykalo I, Ivasiy R, Madden LM, Bromberg DJ, Haddad M, Morozova O, Oliveros D, Ahmad B, Dvoriak S, Altice FL. Integrating Methadone Services Into Primary Care in Ukraine: Two-Year Outcomes From a Randomized Trial. Ann Intern Med. 2026 Feb;179(2):177-186. doi: 10.7326/ANNALS-25-01764. Epub 2025 Dec 9.
Machavariani E, Bromberg DJ, Dumchev K, Esserman D, Earnshaw VA, Pykalo I, Filippovich M, Ivasiy R, Ahmad B, Long J, Haddad MS, Madden LM, Oliveros D, Dvoriak S, Altice FL. Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine. Int J Drug Policy. 2025 Feb;136:104682. doi: 10.1016/j.drugpo.2024.104682. Epub 2024 Dec 19.
Frederick Altice, MD
Yale University
1,590 participants (actual enrollment reported by the registry).
First Submitted
June 10, 2021
First Posted
June 15, 2021
Study Start
May 1, 2017
Actual (reported)Transforming Recovery Through Exercise and Community
Contact the study team to confirm eligibility.
Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, Madden LM, Bromberg DJ, Haddad M, Morozova O, Ahmad B, Gomez DO, Farnum SO, Dvoriak S, Altice FL. Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine. Contemp Clin Trials. 2024 Nov;146:107690. doi: 10.1016/j.cct.2024.107690. Epub 2024 Sep 14.
Pashchenko O, Bromberg DJ, Dumchev K, LaMonaca K, Pykalo I, Filippovych M, Esserman D, Polonsky M, Galvez de Leon SJ, Morozova O, Dvoriak S, Altice FL. Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial. PLOS Glob Public Health. 2022 Nov 2;2(11):e0000344. doi: 10.1371/journal.pgph.0000344. eCollection 2022.
Primary Completion
June 30, 2024
Actual (reported)Study Completion
June 30, 2024
Actual (reported)Last Updated
September 23, 2026
Results First Posted
September 23, 2026
Record last verified: 2026-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: